Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04233346
What this trial is testing

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Otsuka Beijing Research Institute 93
Testing effectiveness (Phase 2)Ended earlyNCT01534143
What this trial is testing

High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Barbara Ann Karmanos Cancer Institute 1
Not applicableStudy completedNCT00001715
What this trial is testing

Evaluation of Patients With Blood Disorders

Who this might be right for
Hematologic Disease
National Institutes of Health Clinical Center (CC) 898
Testing effectiveness (Phase 2)Study completedNCT03157635
What this trial is testing

Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Paroxysmal Hemoglobinuria, Nocturnal
Hoffmann-La Roche 59
Not applicableUnknownNCT06026618
What this trial is testing

Perioperative Management of Preoperative Anemia in Colorectal Cancer

Who this might be right for
AnemiaColorectal Cancer
Consorci Sanitari Integral 1,294
Not applicableLooking for participantsNCT05682924
What this trial is testing

Condition Vasoregulation Function Endothelium in Patients With CML Getting TKI II Generation Bosutinib

Who this might be right for
Chronic Myeloid Leukaemia
Samara State Medical University 105
Testing effectiveness (Phase 2)UnknownNCT01642979
What this trial is testing

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Paroxysmal Nocturnal HemoglobinuriaHemoglobinuriaHemoglobinuria, Paroxysmal+6 more
Institute of Hematology & Blood Diseases Hospital, China 120
Testing effectiveness (Phase 2)Study completedNCT01883362
What this trial is testing

Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 60
Early research (Phase 1)Ended earlyNCT05622058
What this trial is testing

ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Who this might be right for
Prevention of Chemotherapy-induced Myelosuppression
Aileron Therapeutics, Inc. 6
Early research (Phase 1)Study completedNCT02745743
What this trial is testing

Phase I Trial of BAY1251152 for Advanced Blood Cancers

Who this might be right for
Hematologic Neoplasms
Bayer 21
Large-scale testing (Phase 3)Study completedNCT00004218
What this trial is testing

Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Leukemia Research Fund
Testing effectiveness (Phase 2)Study completedNCT02139280
What this trial is testing

Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy

Who this might be right for
Hematologic Malignancies
Dartmouth-Hitchcock Medical Center 58
Very early researchUnknownNCT03795779
What this trial is testing

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes+2 more
iCell Gene Therapeutics 20
Large-scale testing (Phase 3)Ended earlyNCT00256776
What this trial is testing

MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation

Who this might be right for
Multiple Myeloma
European Society for Blood and Marrow Transplantation 269
Testing effectiveness (Phase 2)Study completedNCT00006013
What this trial is testing

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fox Chase Cancer Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT07148180
What this trial is testing

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

Who this might be right for
Acute Myeloid Leukaemia (AML)LeukemiaBlood Cancer+1 more
Jacqueline Garcia, MD 31
Testing effectiveness (Phase 2)Study completedNCT02340780
What this trial is testing

Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Canadian Cancer Trials Group 14
Testing effectiveness (Phase 2)Looking for participantsNCT07609862
What this trial is testing

Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies

Who this might be right for
Mantle Cell Lymphoma (MCL)Diffuse Large B-Cell Lymphoma (DLBCL)Follicular Lymphoma ( FL)+2 more
Guangzhou Lupeng Pharmaceutical Company LTD. 92
Testing effectiveness (Phase 2)Looking for participantsNCT06049290
What this trial is testing

A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Nanjing Leads Biolabs Co.,Ltd 342
Large-scale testing (Phase 3)Ended earlyNCT01339910
What this trial is testing

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

Who this might be right for
Leukemia, Myelocytic, Acute
Medical College of Wisconsin 272
Next Page